SIGNIFOR® LAR is a rare disease drug indicated for patients with Cushing’s disease or acromegaly, for whom pituitary surgery was neither an option nor a cure. The goal was to create a powerful, unified branding effort for the dual relaunch of SIGNIFOR LAR for Cushing’s disease and acromegaly.
The campaign objective is clear: use SIGNIFOR LAR to settle the cortisol storm by targeting key SST receptors in the pituitary gland—located in the brain—to inhibit ACTH and decrease cortisol secretion.
Cushing's Disease
Acromegaly
